Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04772157 · ClinicalTrials.gov registry record
Safe Emergency Department DIscharGE Rate (SEIGE)
A clinical trial, sponsored by Hennepin Healthcare Research Institute.
- Completed
- Registry status
- 1,000
- Enrollment target
NCT04772157 is a clinical trial that has completed, run by Hennepin Healthcare Research Institute. The registered enrollment target is 1,000 participants.
The verdict
NCT04772157 has completed, sponsored by Hennepin Healthcare Research Institute.
- COMPLETED
- Registry status
- 1,000 participants
- Enrollment target
Study Summary
The Siemens POC High Sensitivity Troponin-I Test System is an in vitro diagnostic test for the quantitative measurement of cardiac troponin I (cTn-I) in fresh human capillary (fingerstick) whole blood, and lithium-heparinized venous whole blood or plasma, to be used by healthcare professionals at the point of care (POC) as well as in the clinical laboratory. The Siemens POC High Sensitivity Troponin-I Test System is to be used as an aid in the diagnosis of myocardial infarction (MI).
Interventions
- DIAGNOSTIC_TEST Cardiac Troponin Testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2020-10-13 |
| Est. Completion | 2024-10-13 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04772157
The ClinicalTrials.gov registry entry for NCT04772157 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hennepin Healthcare Research Institute, which has 63 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Cardiac Troponin Testing is the first listed.
NCT04772157 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04772157 about?
NCT04772157 is a clinical study titled "Safe Emergency Department DIscharGE Rate (SEIGE)". The Siemens POC High Sensitivity Troponin-I Test System is an in vitro diagnostic test for the quantitative measurement of cardiac troponin I (cTn-I) in fresh human capillary (fingerstick) whole blood, and lithium-heparinized venous whole blood or plasma, to be used by healthcare professionals at th...
What is the current status of trial NCT04772157?
This trial is currently completed. The enrollment target is 1,000 participants. The study started on 2020-10-13. Estimated completion is 2024-10-13.
What interventions are being tested in trial NCT04772157?
The interventions under investigation include: Cardiac Troponin Testing (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04772157?
This trial is sponsored by Hennepin Healthcare Research Institute, which has 63 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.